Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
[3H]A317491 |
![]() |
![]() |
![]() |
5407 | [3H]A 317491, [3H]A-317491 | ||||
[3H]A-585539 |
![]() |
![]() |
3974 | ||||||
[3H]A778317 |
![]() |
![]() |
4076 | ||||||
[3H]A804598 |
![]() |
![]() |
5408 | [3H]A 804598 | |||||
[3H]A81988 |
![]() |
![]() |
3938 | [3H]-A81988 | |||||
[125I]AB-MECA |
![]() |
![]() |
436 | [125I]-AB-MECA, [125I]5-[6-[(4-aminophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide, [125I]N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide | |||||
[125I]ABOPX |
![]() |
![]() |
452 | [125I]3-(3,4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine | |||||
Ac-[13C,15N]PGP |
![]() |
![]() |
12599 | ||||||
[3H]acetylcholine |
![]() |
![]() |
![]() |
8593 | |||||
[14C]acetylCoA |
![]() |
![]() |
4541 | [14C]-acetylCoA | |||||
[125I][Ac-His1]PACAP-27 |
![]() |
![]() |
2260 | [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||
[35S]ACPPB |
![]() |
![]() |
4584 | [35S]-ACPPB | |||||
[125I]ACTH-(1-24) |
![]() |
![]() |
3767 | [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24) | |||||
[3H]AD5075 |
![]() |
![]() |
2702 | [3H]-AD5075 | |||||
[35S]ADPβS |
![]() |
![]() |
3408 | ||||||
[3H]AF DX-384 |
![]() |
![]() |
368 | [3H]AF-DX 384 | |||||
[125I][Ala1,3,11,15]ET-1 |
![]() |
![]() |
3760 | [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1 | |||||
β-Ala-Lys-AMCA |
![]() |
9501 | β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA | ||||||
[14C]alanine |
![]() |
![]() |
![]() |
4542 | [14C]-alanine | ||||
[3H]alanine |
![]() |
![]() |
![]() |
4543 | [3H]-alanine | ||||
[3H]aldosterone |
![]() |
![]() |
![]() |
3452 | [3H]-aldosterone | ||||
Alexa-488-telenzepine |
![]() |
8600 | |||||||
[3H]-almorexant |
![]() |
![]() |
9465 | ||||||
[3H]alniditan |
![]() |
![]() |
117 | R-91274 | |||||
[18F]altanserin |
![]() |
![]() |
3242 | [18F]altanserin (PET ligand) | |||||
[123I]AM251 |
![]() |
![]() |
744 | ||||||
[3H]AMPA |
![]() |
![]() |
4077 | ||||||
[125I]AM (rat) |
![]() |
![]() |
3768 | [125I]-adrenomedullin, [125I]-AM | |||||
[3H]ancriviroc |
![]() |
![]() |
802 | [3H]SCH 351125, [3H]Sch-351125 | |||||
[125I]angiotensin-(1-7) (human, mouse, rat) |
![]() |
![]() |
5578 | [125I]ang-(1-7) | |||||
[125I]ANP (human) |
![]() |
![]() |
4845 | [125I]-ANP | |||||
[125I]antisauvagine |
![]() |
![]() |
930 | ||||||
[3H]AP4 |
![]() |
![]() |
![]() |
1412 | |||||
[3H]apafant |
![]() |
![]() |
1859 | [3H]WEB 2086 | |||||
[125I]apelin-13 |
![]() |
![]() |
602 | ||||||
[125I]APNEA |
![]() |
![]() |
462 | [3H]N6-2-(4-aminophenyl)ethyladenosine | |||||
[14C]ascorbic acid |
![]() |
![]() |
![]() |
4532 | [14C]-ascorbic acid | ||||
[125I]astressin |
![]() |
![]() |
924 | ||||||
[35S]ATPαS |
![]() |
![]() |
3407 | [35S]-ATPαS | |||||
[35S]ATPγS |
![]() |
![]() |
5406 | [35S]-ATPgammaS | |||||
[3H]AVP (human, mouse, rat) |
![]() |
![]() |
2175 | [3H]arginine vasopressin | |||||
[11C]AZ10419369 |
![]() |
![]() |
3926 | [11C]AZ10419369 (PET ligand) | |||||
[3H]AZ11637326 |
![]() |
![]() |
3971 | ||||||
[125I]7-azido-8-iodoketanserine |
![]() |
![]() |
4763 | [125I]-7-azido-8-iodoketanserine (photoaffinity ligand), [125I]azidoiodoketanserin, [125I]AZIK | |||||
[3H]azietomidate |
![]() |
![]() |
5404 | ||||||
B | Back to top | ||||||||
[3H](R)-(-)-baclofen |
![]() |
![]() |
![]() |
3428 | |||||
[3H]bag-2 |
![]() |
![]() |
8506 | ||||||
[125I]bantag-1 |
![]() |
![]() |
11435 | ||||||
[3H]banyu (I) |
![]() |
![]() |
795 | ||||||
BAY86-7548 |
![]() |
![]() |
11260 | [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2 | |||||
[125I]BAY 55-9837 |
![]() |
![]() |
2281 | ||||||
[125I]BDNF (human) |
![]() |
![]() |
4846 | [125I]-BDNF, [125I]-brain-derived neurotrophic factor | |||||
[125I]-BDZ2 |
![]() |
![]() |
6667 | ||||||
[125I]BgK (W5Y / Y26F) |
![]() |
![]() |
2565 | ||||||
[125I]BH-AMY (rat, mouse) |
![]() |
![]() |
3770 | [125I]-BH-AMY, [125I]-Bolton Hunter amylin | |||||
[125I]BH-MIT1 |
![]() |
![]() |
8522 | ||||||
[125I]BH-NMB (human, mouse, rat) |
![]() |
![]() |
3771 | [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B | |||||
[125I]BH-[Sar9,Met(O2)11]SP |
![]() |
![]() |
3769 | [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P | |||||
[3H]BH-[Sar9,Met(O2)11]SP |
![]() |
![]() |
3811 | [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP | |||||
[3H]BIBP3226 |
![]() |
![]() |
3474 | [3H]-BIBP3226 | |||||
[125I]BIM23027 |
![]() |
![]() |
3772 | [125I]-BIM 23027, [125I]-BIM23027 | |||||
[3H]BK (human, mouse, rat) |
![]() |
![]() |
3812 | [3H]-BK, [3H]-bradykinin | |||||
BODIPY FL-prazosin |
![]() |
13134 | QAPB | ||||||
BODIPY-pirenzepine |
![]() |
8604 | Bodipy[558/568]Pirenzepine, BoPz | ||||||
[125I]BOP |
![]() |
![]() |
1973 | [125I]-I-BOP | |||||
[Bpa6,Tyr10]secretin-27 (rat) |
![]() |
![]() |
1154 | ||||||
[125I]BQ3020 |
![]() |
![]() |
1005 | [125I]-BQ3020 | |||||
[3H]BQ123 |
![]() |
![]() |
1003 | [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu | |||||
[3H]brimonidine (UK14304) |
![]() |
![]() |
![]() |
5386 | [3H]-UK14304 | ||||
[3H]BSP |
![]() |
![]() |
4505 | [3H]-BSP, bromosulfophthalein | |||||
[125I]α-bungarotoxin |
![]() |
![]() |
3972 | ||||||
[3H]α-bungarotoxin |
![]() |
![]() |
3981 | ||||||
[125I]buserelin |
![]() |
![]() |
1167 | [125I]-buserelin | |||||
[11C]butylthio-TZTP |
![]() |
![]() |
3268 | [11C]butylthio-TZTP (PET ligand) | |||||
[3H]BWA868C |
![]() |
![]() |
1899 | ||||||
C | Back to top | ||||||||
[125I]C3a (human) |
![]() |
![]() |
3773 | [125I]-C3a | |||||
[125I]C5a (human) |
![]() |
![]() |
3774 | [125I]-C5a | |||||
[3H]cAMP |
![]() |
![]() |
![]() |
5096 | [3H]-cAMP | ||||
[3H]candesartan |
![]() |
![]() |
6907 | ||||||
[125I]cathepsin G (human) |
![]() |
![]() |
1017 | [125I]cathepsin G | |||||
[3H]CCK-8 (human, mouse, rat) |
![]() |
![]() |
4765 | [3H]-CCK-8 | |||||
[125I]CCL11 (human) |
![]() |
![]() |
794 | [125I]eotaxin | |||||
[125I]CCL16 (human) |
![]() |
![]() |
1275 | [125I]LEC | |||||
[125I]CCL17 (human) |
![]() |
![]() |
3652 | [125I]TARC | |||||
[125I]CCL19 (human) |
![]() |
![]() |
3655 | [125I]ELC | |||||
[125I]CCL1 (human) |
![]() |
![]() |
814 | [125I]I-309, [125I]P500, [125I]TCA-3 | |||||
[125I]CCL20 (human) |
![]() |
![]() |
3654 | [125I]LARC, [125I]MIP-3α | |||||
[125I]CCL21 (human) |
![]() |
![]() |
3656 | [125I]SLC | |||||
[125I]CCL25 (human) |
![]() |
![]() |
3657 | [125I]TECK | |||||
[125I]CCL27 (human) |
![]() |
![]() |
3653 | [125I]CTACK | |||||
[125I]CCL2 (human) |
![]() |
![]() |
762 | [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1 | |||||
[125I]CCL3 (human) |
![]() |
![]() |
763 | [125I]macrophage inflammatory protein-1α, [125I]MIP-1α | |||||
[125I]CCL4 (human) |
![]() |
![]() |
799 | [125I]macrophage inflammatory protein-1β, [125I]MIP-1β | |||||
[125I]CCL5 (human) |
![]() |
![]() |
764 | [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted | |||||
[125I]CCL7 (human) |
![]() |
![]() |
765 | [125I]MCP-3, [125I]monocyte chemotactic protein-3 | |||||
[125I]CCL8 (human) |
![]() |
![]() |
766 | [125I]MCP-2, [125I]monocyte chemotactic protein-2 | |||||
[125I]CCL1 (mouse) |
![]() |
![]() |
5546 | ||||||
[3H]CCPA |
![]() |
![]() |
379 | [3H]-CCPA | |||||
[125I]cetrorelix |
![]() |
![]() |
1186 | ||||||
[125I]CGP 23996 |
![]() |
![]() |
2022 | ||||||
[125I]CGP42112 |
![]() |
![]() |
594 | [125I]-CGP42112, Cgp 42112B, Cgp-42112A | |||||
[125I]CGP 64213 |
![]() |
![]() |
1076 | [125I]CGP64213 | |||||
[125I]CGP 71872 |
![]() |
![]() |
1077 | [125I]CGP71872, CGP 71872 | |||||
[3H](-)CGP 12177 |
![]() |
![]() |
531 | ||||||
[3H]CGP12177 |
![]() |
![]() |
5387 | [3H]-CGP12177, [3H]CGP 12177 | |||||
[3H]CGP27492 |
![]() |
![]() |
5381 | [3H]-3-APPA, [3H]-CGP27492, [3H]3-APPA | |||||
[3H]CGP39653 |
![]() |
![]() |
4078 | ||||||
[3H]CGP 54626 |
![]() |
![]() |
![]() |
1090 | [3H]CGP54626 | ||||
[3H]CGP61594 |
![]() |
![]() |
4079 | [3H]CGP 61594 | |||||
[3H]CGP 62349 |
![]() |
![]() |
3429 | [3H]-CGP 62349, [3H]CGP62349 | |||||
[125I]αCGRP (human) |
![]() |
![]() |
3766 | [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP | |||||
[125I]αCGRP (mouse, rat) |
![]() |
![]() |
6567 | ||||||
[3H]CGS19755 |
![]() |
![]() |
4080 | ||||||
[3H]CGS 21680 |
![]() |
![]() |
![]() |
424 | [3H]-CGS21680 | ||||
[3H]CGS23131 |
![]() |
![]() |
3415 | [3H]CGS 23131, [3H]-CGS23131, LY223982 | |||||
[3H]CGS8216 |
![]() |
![]() |
4366 | ||||||
chenodeoxycholyl-Nε-nitrobenzoxadiazol-lysine |
![]() |
4770 | |||||||
[125I]CHIPS |
![]() |
![]() |
1027 | [125I]chemotaxis inhibitory protein of S. aureus | |||||
[125I]chorionic gonadotropin (human) |
![]() |
![]() |
3775 | [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin | |||||
[3H](+)-cis-diltiazem |
![]() |
![]() |
2512 | [3H]-(+)-cis-diltiazem | |||||
[3H]9-cis-retinoic acid |
![]() |
![]() |
![]() |
5383 | [3H]-9-cis-retinoic acid | ||||
[3H]citalopram |
![]() |
![]() |
4621 | [3H]-citalopram | |||||
[3H]clidinium |
![]() |
![]() |
351 | (-)MQNB, [3H](-)N-methyl-3-quinuclidinyl benzilate, Ro-23773 | |||||
[3H]clonidine |
![]() |
![]() |
![]() |
13162 | |||||
[125I]CNP (human) |
![]() |
![]() |
4847 | [125I]-CNP | |||||
[3H]CNQX |
![]() |
![]() |
![]() |
4081 | |||||
[125I]α-conotoxin MII |
![]() |
![]() |
3975 | ||||||
[3H]Cp-1 |
![]() |
![]() |
9466 | ||||||
[3H]CP55940 |
![]() |
![]() |
![]() |
734 | |||||
[3H]CPP |
![]() |
![]() |
4082 | ||||||
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP |
![]() |
![]() |
3921 | [125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP | |||||
[125I]CRF (ovine) |
![]() |
![]() |
915 | [125I]corticotropin | |||||
[3H]5-CT |
![]() |
![]() |
262 | [3H]5-carboxamidotryptamine, tritiated 5-carbamidotryptamine | |||||
[3H]CTEP |
![]() |
![]() |
6408 | ||||||
[125I]CT (human) |
![]() |
![]() |
3776 | [125I]-calcitonin (Human), [125I]-CT (Human) | |||||
[3H]CTOP |
![]() |
![]() |
12512 | ||||||
[125I]CT (salmon) |
![]() |
![]() |
3777 | [125I]-calcitonin (Salmon), [125I]-CT (Salmon) | |||||
[125I]CXCL10 (human) |
![]() |
![]() |
3660 | [125I]IP-10 | |||||
[125I]CXCL11 (human) |
![]() |
![]() |
3661 | [125I]I-TAC | |||||
[125I]CXCL12α (human) |
![]() |
![]() |
849 | [125I]SDF-1α (human), [125I]stromal cell-derived factor-1α | |||||
[125I]CXCL12β (human) |
![]() |
![]() |
850 | [125I]SDF-1β (human), [125I]stromal cell-derived factor-1β | |||||
[125I]CXCL16 (human) |
![]() |
![]() |
3662 | ||||||
[125I]CXCL1 (human) |
![]() |
![]() |
3677 | [125I]GROα | |||||
[125I]CXCL5 (human) |
![]() |
![]() |
3659 | [125I]ENA-78 | |||||
[125I]CXCL7 (human) |
![]() |
![]() |
3658 | [125I]NAP-2 | |||||
[125I]CXCL8 (human) |
![]() |
![]() |
822 | [125I]IL-8, [125I]interleukin-8 | |||||
[125I]CX3CL1 (human) |
![]() |
![]() |
3664 | [125I]Fractalkine | |||||
[125I]CXCL13 (mouse) |
![]() |
![]() |
8631 | ||||||
Cy3B-NMU-8 |
![]() |
3863 | |||||||
Cy3B-telenzepine |
![]() |
8598 | |||||||
[Cy5-Lys19]NPS |
![]() |
9166 | Cy5-hNPS | ||||||
[3H]cytisine |
![]() |
![]() |
3979 | ||||||
D | Back to top | ||||||||
[3H][D-Ala2]deltorphin I |
![]() |
![]() |
9065 | ||||||
D-Ala-Lys-AMCA |
![]() |
5421 | (D)-Ala-(L)-Lys-Nε-AMCA, D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid | ||||||
[3H]DAMGO |
![]() |
![]() |
3815 | [3H]-DAMGO, [tyrosyl 3,5-3H]DAMGO | |||||
[3H]4-DAMP |
![]() |
![]() |
11497 | ||||||
[3H]darifenacin |
![]() |
![]() |
319 | ||||||
[3H]D-aspartic acid |
![]() |
![]() |
![]() |
4698 | [3H]-D-aspartate, [3H]-D-aspartic acid | ||||
[35S]dATPαS |
![]() |
![]() |
3406 | [35S]-dATPαS | |||||
[3H]d[Cha4]AVP |
![]() |
![]() |
2227 | [3H][1-deamino-4-cyclohexylalanine]AVP, [3H][deamino-Cys1,Cha4]AVP | |||||
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP |
![]() |
![]() |
2230 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP | |||||
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP |
![]() |
![]() |
2231 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP | |||||
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP |
![]() |
![]() |
2232 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP | |||||
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP |
![]() |
![]() |
2233 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | |||||
[3H]d(CH2)5[Tyr(Me)2]AVP |
![]() |
![]() |
3813 | [3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP | |||||
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT |
![]() |
![]() |
3778 | [125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT | |||||
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT |
![]() |
![]() |
2218 | β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT, [125I]ZOTA, d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin | |||||
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT |
![]() |
![]() |
2220 | [125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin, [125I]OTA | |||||
[3H]d[D-Arg8]VP |
![]() |
![]() |
5403 | [3H]-d[D-Arg8]VP, [3H][D-Arg8]vasopressin, [3H]DAVP | |||||
[3H]dDAVP |
![]() |
![]() |
2228 | [3H]deamino arginine vasopressin, [3H]desmopressin | |||||
[3H]dehydroepiandrosterone sulphate |
![]() |
![]() |
5577 | [3H]DHEAS, [3H]dehydroepiandrosterone sulfate | |||||
[3H]deltorphin II |
![]() |
![]() |
3816 | [3H]-deltorphin II | |||||
[3H]2-deoxyglucose |
![]() |
![]() |
4643 | 2-deoxy-D-glucose, 2-DG, [3H]-2-deoxyglucose | |||||
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide |
![]() |
![]() |
1166 | ||||||
[3H]desGly-NH2[D-Ile2,Ile4]VP |
![]() |
![]() |
3817 | [3H]-desGly-NH2[D-Ile2,Ile4]AVP | |||||
[3H](-)devapamil |
![]() |
![]() |
2515 | ||||||
[3H]devazepide |
![]() |
![]() |
3476 | [3H]-devazepide | |||||
[3H]dexamethasone |
![]() |
![]() |
![]() |
3447 | [3H]-dexamethasone | ||||
[3H]digoxin |
![]() |
![]() |
![]() |
4725 | [3H]-digoxin | ||||
[3H]dihydroalprenolol |
![]() |
![]() |
5388 | [3H]-dihydroalprenolol | |||||
[3H]dihydrotestosterone |
![]() |
![]() |
![]() |
3455 | [3H]-dihydrotestosterone | ||||
[3H]dimethyl-W84 |
![]() |
![]() |
364 | ||||||
[3H]-di-o-tolylguanidine |
![]() |
![]() |
6685 | [3H]DOTG | |||||
[3H]diprenorphine |
![]() |
![]() |
1612 | [15,16-3H]diprenorphine | |||||
[125I]DIV880 |
![]() |
![]() |
7771 | ||||||
[3H]dizocilpine |
![]() |
![]() |
4089 | [3H]MK-801 | |||||
[125I]1DMe |
![]() |
![]() |
1483 | ||||||
[3H](+)DOB |
![]() |
![]() |
155 | 4-bromo-2,5-dimethoxyphenylisopropylamine, brolamfetamine | |||||
[125I]DOI |
![]() |
![]() |
169 | ||||||
[111In]DOTA-BOC-ATE |
![]() |
![]() |
2063 | [111In-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE | |||||
[111In]DOTA-dLVT |
![]() |
![]() |
3756 | [111In]-DOTA-dLVT, [111In]-DOTA-Lys8-deamino-vasotocin, [111indium]DOTA-dLVT | |||||
DOTA/Eu relaxin-3 |
![]() |
11912 | |||||||
[111In,90Y]DOTA-LAN |
![]() |
![]() |
2056 | DOTA-conjugated peptide, YIII-DOTA-LAN | |||||
[111In]DOTA-NOC |
![]() |
![]() |
2045 | [111In-DOTA]-NOC, [InIII-DOTA]-NOC, [InIII-DOTA]-NOC | |||||
[111In,90Y]DOTA-NOC |
![]() |
![]() |
2057 | 90Y-DOTA-NOC, [90Y-DOTA]-1-Nal3-octreotide, YIII-DOTA-NOC | |||||
[111In]DOTA-NOC-ATE |
![]() |
![]() |
2064 | [111In-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE | |||||
[111In,90Y]DOTA-OC |
![]() |
![]() |
2058 | [3Y]DOTA-OC, [3Y]DOTA-octreotide, YIII-DOTA-OC | |||||
[111In,90Y]DOTA-TOC |
![]() |
![]() |
2059 | YIII-DOTA-TOC, YIII-DOTA-Tyr3-octreotide, YIII-DOTA-TOC | |||||
[11C]doxepin |
![]() |
![]() |
![]() |
3958 | [11C]-doxepin | ||||
[3H]DPCPX |
![]() |
![]() |
406 | [3H]-DPCPX | |||||
[3H]DPDPE |
![]() |
![]() |
3819 | [3H]-[d-Pen2,d-Pen5]-Enkephalin, [3H]-DPDPE | |||||
[11C]DTBZ |
![]() |
![]() |
4608 | [11C]-DTBZ , [11C]-DTBZ (PET ligand), dihydrotetrabenazine | |||||
[125I]α-DTX |
![]() |
![]() |
2564 | ||||||
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14) |
![]() |
![]() |
631 | [125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14, [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14) | |||||
[125I][D-Tyr6]bombesin-(6-13)-methyl ester |
![]() |
![]() |
628 | ||||||
[d-Tyr-14C]TAK-448 |
![]() |
![]() |
10223 | ||||||
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33 |
![]() |
![]() |
6666 | ||||||
E | Back to top | ||||||||
[125I]EGF (human) |
![]() |
![]() |
4848 | [125I]-epidermal growth factor | |||||
[3H]eglumegad |
![]() |
![]() |
![]() |
1396 | [3H]LY354740 | ||||
[3H]eletriptan |
![]() |
![]() |
118 | ||||||
[3H]EMPA |
![]() |
![]() |
9467 | ||||||
[3H]EM-TBPC |
![]() |
![]() |
1390 | ||||||
[3H]enadoline |
![]() |
![]() |
3475 | [3H]-CI977, [3H]-enadoline, [3H]CI-977, [3H]CI977 | |||||
[125I]epibatidine |
![]() |
![]() |
3976 | ||||||
[3H]epibatidine |
![]() |
![]() |
3977 | ||||||
[3H]eprosartan |
![]() |
![]() |
3940 | [3H]-eprosartan, [3H]SK&F 108566 | |||||
[3H]17β-estradiol |
![]() |
![]() |
![]() |
1012 | [3H]-estradiol, [3H]-estrogen, [3H]E2, [3H]estradiol | ||||
[3H]estradiol-17β-glucuronide |
![]() |
![]() |
![]() |
4687 | [3H]-estradiol-17β-glucuronide | ||||
[3H]estrone-3-sulphate |
![]() |
![]() |
4748 | [3H]-estrone hydrogen sulfate, [3H]-estrone-3-sulphate, [3H]estrone-3-sulfate | |||||
[3H]ETB-TBOA |
![]() |
![]() |
4492 | [3H]-ETB-TBOA | |||||
[125I]ET-2 (human) |
![]() |
![]() |
992 | [125I]endothelin-2 | |||||
[125I]ET-1 (human, mouse, rat) |
![]() |
![]() |
991 | [125I]endothelin-1 | |||||
[18F]ET-1 (human, mouse, rat) |
![]() |
![]() |
994 | [18F]endothelin-1 | |||||
Eu-DTPA-hC3a |
![]() |
11286 | |||||||
Eu-DTPA-[Ser27, Nle70]hC5a |
![]() |
12516 | |||||||
europium-labelled INSL3 |
![]() |
3875 | |||||||
europium-labelled INSL5 |
![]() |
4375 | |||||||
europium-labelled mouse INSL5 |
![]() |
6522 | |||||||
europium-labelled R3(B1-22R) |
![]() |
8342 | Eu R3(B1-22R) | ||||||
europium-labelled relaxin |
![]() |
3874 | europium-labelled H2 relaxin | ||||||
europium-labelled relaxin-3-B/INSL5 A chimera |
![]() |
4374 | Eu-R3/I5, europium-labelled H3-B/INSL5 A chimera | ||||||
[125I]exendin-(9-39) |
![]() |
![]() |
1137 | [125I]exendin (9-39) | |||||
[125I]EXP985 |
![]() |
![]() |
3942 | [125I]-EXP985 | |||||
[125I]EYF |
![]() |
![]() |
1488 | [125I]-EYF | |||||
[3H]EYF |
![]() |
![]() |
4021 | [3H]-EYF | |||||
F | Back to top | ||||||||
[3H]fananserin |
![]() |
![]() |
3229 | [3H]RP-62203, [3H]RP62203 | |||||
[3H]fenobam |
![]() |
![]() |
![]() |
1433 | |||||
[18F]FEPPG |
![]() |
![]() |
11367 | (S)-N-(2-amino-3-(4-(2-(fluoro-18F)ethoxy)phenyl)propanoyl)-N-methylglycine | |||||
[18F]FITM |
![]() |
![]() |
6213 | ||||||
florbetaben |
![]() |
![]() |
![]() |
7769 | [18F]BAY 94-9172, AV-1, BAY 94-9172, Neuraceq® | ||||
florbetapir |
![]() |
![]() |
![]() |
7344 | AMYViD®, AV-45, florbetapir (18F) | ||||
flortaucipir (18F) |
![]() |
![]() |
![]() |
9100 | 18F-AV-1451, [F-18]T807, flortaucipir F-18, LY-3191748, Tauvid® | ||||
F2L-[125I]Tyr |
![]() |
![]() |
1045 | ||||||
Flu-CCL3 |
![]() |
760 | Flu-LD78α, Flu-MIP-1α, fluorescent macrophage inflammatory protein-1α | ||||||
[11C]flumazenil |
![]() |
![]() |
![]() |
4367 | [11C]flumazenil (PET ligand) | ||||
[3H]flunitrazepam |
![]() |
![]() |
4360 | ||||||
fluorescent MIF ligand B |
![]() |
![]() |
9987 | ||||||
[18F]fluoroethylflumazenil |
![]() |
![]() |
4368 | [18F]fluoroethylflumazenil (PET ligand) | |||||
[3H](+)-fluprostenol |
![]() |
![]() |
3417 | [3H]-(+)-fluprostenol | |||||
flutemetamol |
![]() |
![]() |
![]() |
7342 | 18F-flutemetamol, [18F]flutemetamol, flutemetamol F18 | ||||
[18F]FMBP |
![]() |
![]() |
12670 | ||||||
[3H]fMet-Leu-Phe |
![]() |
![]() |
1018 | [3H]fMet-Leu-Phe, [3H]fMLP | |||||
fMet-Leu-Phe-Ile-Ile-Lys-FITC |
![]() |
5843 | |||||||
[3H]folic acid |
![]() |
![]() |
![]() |
4562 | [3H]-folic acid | ||||
[3H]folinic acid |
![]() |
![]() |
6690 | ||||||
(3,5)-[19F]2-Phe-ψ-Ala |
![]() |
![]() |
11370 | (3,5)-difluoro Phe-ψ-Ala | |||||
[18F]FPIT |
![]() |
![]() |
6392 | ||||||
[18F]FP-TZTP |
![]() |
![]() |
3266 | [18F]FP-TZTP (PET ligand) | |||||
[125I]FSH (human) |
![]() |
![]() |
3780 | [125I]-follicle-stimulating hormone, [125I]-FSH | |||||
2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 |
![]() |
4050 | Alexa Fluor 594-2fLI | ||||||
[3H]2-furoyl-LIGRL-NH2 |
![]() |
![]() |
6660 | ||||||
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2 |
![]() |
![]() |
4049 | [3H]propionyl-2fLI | |||||
G | Back to top | ||||||||
[3H]GABA |
![]() |
![]() |
![]() |
5410 | |||||
[3H]gabazine |
![]() |
![]() |
4083 | SR95531 | |||||
[125I]gastrin |
![]() |
![]() |
3781 | [125I]-gastrin | |||||
[3H]gastrin |
![]() |
![]() |
3821 | [3H]-gastrin | |||||
[3H]GBR12935 |
![]() |
![]() |
4638 | [3H]-GBR12935 | |||||
[125I]GDNF (rat) |
![]() |
![]() |
4851 | [125I]-GDNF (rat) | |||||
GE-137 |
![]() |
8585 | |||||||
[125I]GHRH (human) |
![]() |
![]() |
3783 | [125I]-GHRH, [125I]-growth hormone releasing hormone, [125I]-Tyr10-hGHRH(1-44)NH2, [125I]GHRH(1-44)NH2 | |||||
[125I]GIP (human) |
![]() |
![]() |
1131 | [125I]-GIP, [125I]gastric inhibitory polypeptide | |||||
[125I]GLP-1-(7-36)-amide |
![]() |
![]() |
1134 | [125I]GLP-1, [125I]GLP-1(7-36)amide, [125I]glucagon-like peptide 1 (7-36) | |||||
[125I]GLP-1-(7-37) (human) |
![]() |
![]() |
3784 | [125I]-GLP-1(7-37), [125I]-glucagon-like peptide-1(7-37), [125I]GLP-1(7-37) | |||||
[125I][Glp65Nle75,Tyr77]apelin-13 |
![]() |
![]() |
3761 | [125I](Pyr1)[Nle75,Tyr77]-apelin-13, [125I]-[Glp65Nle75,Tyr77]apelin-13, [125I][Glu65,Nle75,Tyr77]apelin-13 | |||||
[125I]glucagon (human, mouse, rat) |
![]() |
![]() |
3785 | [125I]-glucagon | |||||
[14C]glutamine |
![]() |
![]() |
![]() |
4633 | [14C]-glutamine | ||||
[3H]glutamine |
![]() |
![]() |
![]() |
4634 | [3H]-glutamine | ||||
[14C]glycine |
![]() |
![]() |
![]() |
4635 | [14C]-glycine | ||||
[3H]glycine |
![]() |
![]() |
![]() |
4084 | |||||
glycyl-[13C3]-sarcosine |
![]() |
![]() |
12598 | ||||||
[11C]GlySar |
![]() |
![]() |
4489 | [11C]-GlySar, [11C]glycylsarcosine | |||||
[14C]GlySar |
![]() |
![]() |
4599 | [14C]-GlySar, glycylsarcosine | |||||
[3H]GlySar |
![]() |
![]() |
4659 | [3H]-GlySar, tritiated glycylsarcosine | |||||
[125I]GnRH I (human, mouse, rat) |
![]() |
![]() |
3786 | [125I]-GnRH I, [125I]-gonadotropin-releasing hormone I | |||||
[125I]GnRH II (human) |
![]() |
![]() |
3787 | [125I]-GnRH II, [125I]-gonadotropin-releasing hormone II | |||||
[125I]GR231118 |
![]() |
![]() |
1531 | [125I]1229U91, [125I]GW1229 | |||||
[3H]GR100679 |
![]() |
![]() |
3822 | [3H]-GR100679 | |||||
[3H]GR 113808 |
![]() |
![]() |
259 | GR 125487 [H3], GR113808 | |||||
[3H]GR 125,743 |
![]() |
![]() |
131 | [3H]GR125743, GR125743 | |||||
[3H]GR65630 |
![]() |
![]() |
2303 | [3H]-GR65630 | |||||
[3H]granisetron |
![]() |
![]() |
2292 | [3H]-BRL-43694, [3H]-granisetron | |||||
[125I]GRP (human) |
![]() |
![]() |
3788 | [125I]-gastrin-releasing peptide, [125I]-GRP | |||||
[11C]GSK215083 |
![]() |
![]() |
8430 | ||||||
[3H]GSK931145 |
![]() |
![]() |
4490 | [3H]-GSK931145 | |||||
[125I]GTI |
![]() |
![]() |
3250 | serotonin-5-O-carboxymethyl-glycyl-(125I)tyrosinamide | |||||
[3H]GW2331 |
![]() |
![]() |
2706 | ||||||
H | Back to top | ||||||||
[3H]haTRAP |
![]() |
![]() |
3823 | [3H]-haTRAP, Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide | |||||
HEAT (BE2254) |
![]() |
![]() |
482 | [125I] BE2254, [125I] HEAT, [125I]-HEAT, [125I]BE2254 | |||||
[125I]HEAT (BE2254) |
![]() |
![]() |
500 | 2-[[2-(4-hydroxy-3-iodanylphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one, 2-{p-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl}-tetralone, [125I]BE-2254, HEAT | |||||
[3H]HEMADO |
![]() |
![]() |
5736 | ||||||
[3H]hemicholinium-3 |
![]() |
![]() |
4493 | [3H]-HC-3 , [3H]-hemicholinium-3, [3H]HC-3 | |||||
[125I][His9]ghrelin (human) |
![]() |
![]() |
1094 | [125I-His9]ghrelin, [125I] His9-ghrelin (human) | |||||
[3H]histamine |
![]() |
![]() |
![]() |
1247 | |||||
[14C]histidine |
![]() |
![]() |
4623 | [14C]-histidine | |||||
[3H]histidine |
![]() |
![]() |
4670 | [3H]-histidine | |||||
[125I]Hpp-desArg10HOE140 |
![]() |
![]() |
3791 | [125I]-Hpp-desArg9HOE140 | |||||
[125I]HPP-HOE140 |
![]() |
![]() |
11436 | [125I]-3-4-hydroxyphenyl-propionyl-d-Arg0-[Hyp3,Thi5,d-Tic7,Oic8]bradykinin | |||||
[125I]-HPP-icatibant |
![]() |
![]() |
11158 | [(125)I]-HPP-Hoe 140, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-BK, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin, [125I]3-4 hydroxyphenyl-propionyl-icatibant | |||||
[3H]5-HT |
![]() |
![]() |
3248 | [3H]-5-HT | |||||
[3H]HU-243 |
![]() |
![]() |
735 | ||||||
I | Back to top | ||||||||
[35S]ibutamoren |
![]() |
![]() |
1097 | [35S]MK-0677 | |||||
[3H]ICI-198615 |
![]() |
![]() |
3414 | [3H]-ICI198615, [3H]ICI-198,615, [3H]ICI198615 | |||||
ICOA-13 |
![]() |
11196 | |||||||
[125I]ICYP |
![]() |
![]() |
562 | [125I]cyanopindolol, [125I]iodocyanopindolol | |||||
[3H]iloprost |
![]() |
![]() |
1966 | [3H]-Iloprost, [3H]ciloprost, [3H]ventavis | |||||
[125I]INSL3 (human) |
![]() |
![]() |
1996 | ||||||
[125I]INSL5 (human) |
![]() |
![]() |
2001 | [125I]insulin-like peptide 5 | |||||
iodipamide |
![]() |
![]() |
![]() |
7400 | adipiodone meglumine, iodipamic acid, radio-cholografin | ||||
[125I]iodoaminopotentidine |
![]() |
![]() |
1230 | [125I]-iodoaminopotentidine, [125I]APT | |||||
[123I]iodobenzovesamicol |
![]() |
![]() |
4762 | [123I]-IBVM, [123I]-iodobenzovesamicol | |||||
2-iodo-[125I]5MCA-NAT |
![]() |
![]() |
5396 | 2-iodo-[125I]-5MCA-NAT | |||||
[125I]iodophenpropit |
![]() |
![]() |
3960 | ||||||
[123I]iodoproxyfan |
![]() |
![]() |
1264 | [125I]-iodoproxyfan | |||||
[125I](3-iodo-Tyr13)-MCH |
![]() |
![]() |
1316 | ||||||
[125I]iodovinyl-TBZ |
![]() |
![]() |
4764 | [125I]-iodovinyl-TBZ , [125I]-iodovinyltetrabenazine | |||||
[3H]iperoxo |
![]() |
![]() |
12486 | ||||||
[3H]-IPP |
![]() |
![]() |
11368 | ||||||
[3H]irbesartan |
![]() |
![]() |
6908 | ||||||
[125I]IRL1620 |
![]() |
![]() |
1007 | [125I]-IRL1620, [125I]IRL 1620 | |||||
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 |
![]() |
12493 | |||||||
[3H](+)-isradipine |
![]() |
![]() |
2733 | (+)-[3H]isradipine, (+)-[3H]O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 3H-(+)-PN 200-110 | |||||
[125I-Tyr]Ac2-26 |
![]() |
![]() |
6198 | [125I]ANXA1-derived peptide | |||||
J | Back to top | ||||||||
[3H]JB-93182 |
![]() |
![]() |
908 | ||||||
[11C]JNJ-16567083 |
![]() |
![]() |
3418 | [11C]-JNJ-16567083 | |||||
[3H]JNJ-40068782 |
![]() |
![]() |
6331 | ||||||
[3H]JNJ 7777120 |
![]() |
![]() |
1279 | [3H]-JNJ7777120 | |||||
K | Back to top | ||||||||
[3H]kainate |
![]() |
![]() |
4085 | ||||||
[125I]KC-Tyr |
![]() |
![]() |
832 | ||||||
[3H]ketanserin |
![]() |
![]() |
![]() |
197 | |||||
[125I]kisspeptin-10 (human) |
![]() |
![]() |
1281 | [125I]-KP10, [125I]KP-10 | |||||
[125I]kisspeptin-13 (human) |
![]() |
![]() |
3792 | [125I]-kisspeptin13, [125I]-KP13, [125I]KP13 | |||||
[125I]kisspeptin-14 (human) |
![]() |
![]() |
4013 | [125I]KP14 | |||||
[125I]kisspeptin-54 (human) |
![]() |
![]() |
1282 | [125I]KP-54, [125I]metastin | |||||
L | Back to top | ||||||||
[125I]L703,606 |
![]() |
![]() |
3471 | [125I]-L703,606, [125I]L703606 | |||||
[125I]L750667 |
![]() |
![]() |
3295 | [125I]-L750667 | |||||
[3H]L158809 |
![]() |
![]() |
3939 | [3H]-L158809, [3H]L-158,809 | |||||
[3H]L365260 |
![]() |
![]() |
3477 | [3H]L-365,260 | |||||
[3H]L655708 |
![]() |
![]() |
4363 | ||||||
[3H]L689560 |
![]() |
![]() |
4086 | ||||||
[3H]L748337 |
![]() |
![]() |
13196 | ||||||
[3H]L-aspartic acid |
![]() |
![]() |
![]() |
4534 | [3H]-L-aspartate, [3H]-L-aspartic acid | ||||
LDV-FITC |
![]() |
6759 | |||||||
[3H]Leu-N/OFQ |
![]() |
![]() |
3824 | [3H]-Leu-N/OFQ, [3H]-Leu-nociceptin.orphanin FQ | |||||
[125I][Leu31,Pro34]NPY |
![]() |
![]() |
3762 | [125I]-[Leu31,Pro34]neuropeptide Y, [125I]-[Leu31,Pro34]NPY | |||||
[125I]LH |
![]() |
![]() |
3793 | [125I]-LH, [125I]-luteinising hormone, [125I]-luteinizing hormone | |||||
[3H]-LKP |
![]() |
![]() |
11369 | ||||||
[3H]losartan |
![]() |
![]() |
![]() |
3941 | [3H]-losartan | ||||
[3H]LPA |
![]() |
![]() |
5395 | [3H]-LPA, [3H]1-oleoyl-LPA, [3H]lysophosphatidic acid | |||||
[125I]LSD |
![]() |
![]() |
261 | [125I]lysergamid, [125I]lysergic acid diethylamide, [125I]lysergide, [125I]N,N-diethyllysergamide | |||||
[3H]LSD |
![]() |
![]() |
219 | [3H]lysergic acid diethylamide, [3H]lysergide, [3H]N,N-diethyllysergamide | |||||
[3H]LTB4 |
![]() |
![]() |
3413 | ||||||
[3H]LTC4 |
![]() |
![]() |
6195 | ||||||
[3H]LTD4 |
![]() |
![]() |
3412 | [3H]-LTD4 | |||||
[3H]LTE4 |
![]() |
![]() |
5863 | ||||||
[125I]LTT-SRIF-28 |
![]() |
![]() |
2023 | 3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28, 3-[125I]LTT-SRIF-28, [125I](Leu8, D-Trp22, Tyr25)-somatostatin-28 | |||||
[3H]LXA4 |
![]() |
![]() |
3411 | [3H]-LXA4 | |||||
[3H]LY278584 |
![]() |
![]() |
4087 | ||||||
[3H]LY334370 |
![]() |
![]() |
151 | LY334370 | |||||
[3H]LY341495 |
![]() |
![]() |
![]() |
1399 | [3H]α-9'-xantheylmethyl-2-(carboxycyclopropyl)glycine | ||||
[3H]Lys-[des-Arg9]BK |
![]() |
![]() |
3825 | [3H]-Lys-[des-Arg9]-bradykinin, [3H]-Lys-[des-Arg9]BK | |||||
[3H]Lys-[Leu8][des-Arg9]BK |
![]() |
![]() |
3826 | [3H]-Lys-[Leu8][des-Arg9]-bradykinin, [3H]-Lys-[Leu8][des-Arg9]BK | |||||
M | Back to top | ||||||||
maltotriose-[125I][Tyr3,Thr8]octreotide |
![]() |
![]() |
5631 | [125I]-Mtr-TOCA, maltotriose-[125I]-Tyr3-octreotate | |||||
[3H]maraviroc |
![]() |
![]() |
803 | [3H]UK 427,857, [3H]UK-427,857 | |||||
[3H]mazindol |
![]() |
![]() |
4591 | [3H]-mazindol | |||||
[125I]MCH (human, mouse, rat) |
![]() |
![]() |
1296 | [125I]-melanin-concentrating hormone | |||||
[3H]MCH (human, mouse, rat) |
![]() |
![]() |
3827 | [3H]-MCH, [3H]-melanin-concentraing hormone | |||||
[3H]MDL105519 |
![]() |
![]() |
4088 | ||||||
MDP-rhodamine |
![]() |
9506 | MDP-Hex-Rhodamine B | ||||||
[3H]αβ-meATP |
![]() |
![]() |
![]() |
5405 | |||||
[3H]meclinertant |
![]() |
![]() |
1583 | [3H]-SR48692, [3H]reminertant, [3H]SR-48692 | |||||
2-[125I]melatonin |
![]() |
![]() |
1344 | 2-[125I]MLT, 2-(125I)Iodomelatonin, 2-iodo-[125I]-melatonin, 2[125I]iodomelatonin | |||||
[3H]melatonin |
![]() |
![]() |
![]() |
1357 | [3H]-melatonin, [3H]MLT | ||||
[125I][MePhe7]NKB |
![]() |
![]() |
3763 | [125I]-[MePhe7]neurokinin A, [125I]-[MePhe7]NKB | |||||
[33P]2MeSADP |
![]() |
![]() |
1774 | [33P]2-methylthio-ADP | |||||
[3H]2MeSADP |
![]() |
![]() |
![]() |
1763 | [3H]2-methylthio-ADP | ||||
[3H]mesulergine |
![]() |
![]() |
232 | ||||||
[3H]meta-chlorophenylbiguanide |
![]() |
![]() |
2304 | ||||||
[14C]metformin |
![]() |
![]() |
![]() |
4503 | [14C]-metformin | ||||
[3H]methotrexate |
![]() |
![]() |
![]() |
4674 | [3H]-methotrexate | ||||
[3H]methoxymethyl-MTEP |
![]() |
![]() |
5394 | [3H]-methoxymethyl-MTEP | |||||
[3H]methoxy-PEPy |
![]() |
![]() |
6425 | ||||||
[14C]methylamine |
![]() |
![]() |
4624 | [14C]-methylamine | |||||
[3H](R)-α-methylhistamine |
![]() |
![]() |
1237 | (R)-[3H]α-methylhistamine, [3H]-R-α-Methylhistamine | |||||
[3H]methyllycaconitine |
![]() |
![]() |
![]() |
3980 | |||||
[3H]methyltrienolone |
![]() |
![]() |
![]() |
3457 | [3H]-R1881, [3H]R1881 | ||||
[3H]MeTRH |
![]() |
![]() |
2141 | [3H]Me-thyrotropin-releasing hormone, [3H]pGlu-His(1(τ)-methyl)-ProNH2 | |||||
[3H]mibolerone |
![]() |
![]() |
3456 | ||||||
[125I]mini-TyrRS |
![]() |
![]() |
818 | 125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase | |||||
[3H]mirogabalin |
![]() |
![]() |
![]() |
12597 | |||||
[125I]MK-678 |
![]() |
![]() |
2061 | ||||||
[18F]MK-1312 |
![]() |
![]() |
6334 | ||||||
[3H]MK-912 |
![]() |
![]() |
527 | [3H]L-657,743 | |||||
[3H]M-MPEP |
![]() |
![]() |
![]() |
1425 | [3H]-M-MPEP | ||||
MMP13 tracer [18F]5j |
![]() |
![]() |
12669 | ||||||
[11C]MMTP |
![]() |
![]() |
6212 | ||||||
[125I]motilin (human) |
![]() |
![]() |
3794 | [125I]-motilin | |||||
[3H]MRE 3008F20 |
![]() |
![]() |
477 | ||||||
MRS4174 |
![]() |
9470 | derivative 30 [PMID: 25299434] | ||||||
MRS4183 |
![]() |
9471 | compound 11 [PMID: 26303895] | ||||||
[32P]MRS2500 |
![]() |
![]() |
1726 | [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate | |||||
[3H]MRS1754 |
![]() |
![]() |
453 | [3H]-MRS1754 | |||||
[3H]MRS2279 |
![]() |
![]() |
1727 | [3H]-MRS2279 | |||||
MRS4162-BODIPY conjugate |
![]() |
9469 | BODIPY 630/650 conjugate 28 | ||||||
[14C]MTEP |
![]() |
![]() |
1429 | LS-131849 | |||||
[3H]muscimol |
![]() |
![]() |
4090 | ||||||
Mz438 |
![]() |
12805 | compound 9a [PMID: 37463496], Mz-438 | ||||||
N | Back to top | ||||||||
[3H]naloxone |
![]() |
![]() |
![]() |
1676 | [N-allyl-2,3-3H]naloxone | ||||
[3H]naltriben |
![]() |
![]() |
![]() |
3828 | [3H]-naltriben | ||||
[3H]naltrindole |
![]() |
![]() |
![]() |
3829 | [3H]-naltrindole | ||||
Nanoluciferase-labelled relaxin |
![]() |
11464 | |||||||
NanoLuc-INSL3 |
![]() |
11913 | |||||||
NanoLuc R3/I5 chimera |
![]() |
11465 | |||||||
[3H]NBI-49202 |
![]() |
![]() |
1187 | ||||||
[125I]N-biotin-[Ahx0, Bpa3]U-II (human) |
![]() |
![]() |
9440 | ||||||
[125I]NDP-MSH |
![]() |
![]() |
1326 | [125I]-NDP-MSH, [125I][Nle4,dPhe7]α-MSH | |||||
[3H]NECA |
![]() |
![]() |
![]() |
425 | [3H]adenosine-5'-(N-ethylcarboxamide) | ||||
[3H]nelivaptan |
![]() |
![]() |
3483 | [3H]-SSR149415, [3H]SSR149415 | |||||
[3H]nemonapride |
![]() |
![]() |
![]() |
962 | |||||
[125I]neuromedin U-25 (human) |
![]() |
![]() |
1474 | [125I]NmU-25 (human), [125I]neuromedin U, [125I]NMU-25 | |||||
[125I]neuromedin U-8 (pig) |
![]() |
![]() |
1476 | [125I]NmU-8 (pig), porcine [125I]neuromedin U-8 | |||||
[125I]neuromedin U-23 (rat) |
![]() |
![]() |
1475 | [125I]NmU-23 (rat), rat [125I]neuromedin U-23 | |||||
[125I]neurotensin (human, mouse, rat) |
![]() |
![]() |
1574 | [125I]NT | |||||
[3H]neurotensin (human, mouse, rat) |
![]() |
![]() |
3830 | [3H]-neurotensin | |||||
[3H]NFPS |
![]() |
![]() |
4619 | [3H]-NFPS | |||||
[3H]NGD941 |
![]() |
![]() |
3297 | [3H]-NGD941, [3H]NGD 94-1 | |||||
[125I]NGF (human) |
![]() |
![]() |
4849 | [125I]-nerve growth factor | |||||
[3H]nicotine |
![]() |
![]() |
3978 | ||||||
[3H]nicotinic acid |
![]() |
![]() |
![]() |
1594 | [3H]-nicotinic acid | ||||
[3H]nisoxetine |
![]() |
![]() |
4636 | [3H]-nisoxetine | |||||
[3H]nitrobenzylmercaptopurine ribonucleoside |
![]() |
![]() |
4511 | [3H]NBMPR, [3H]-NBTI , [3H]NBTI | |||||
[125I]NKA (human, mouse, rat) |
![]() |
![]() |
3795 | [125I]-neurokinin A, [125I]-NKA | |||||
[125I][Nle75,Tyr77]apelin-36 (human) |
![]() |
![]() |
603 | ||||||
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat) |
![]() |
![]() |
1791 | ||||||
[3H]NLX-112 |
![]() |
![]() |
![]() |
3925 | [3H]F13640 | ||||
[3H]N-methyl-AZ10419369 |
![]() |
![]() |
3219 | [N-methyl-3H3]AZ10419369 | |||||
[3H]N5-methylfolate |
![]() |
![]() |
6689 | ||||||
N-[3H]α-methylhistamine |
![]() |
![]() |
1240 | [3H]-Na-methylhistamine, [3H]NAMH | |||||
N-[3H]methylhistamine |
![]() |
![]() |
1241 | ||||||
[3H]N-methyl scopolamine |
![]() |
![]() |
317 | [3H]N-methylscopolamine, [3H]NMS | |||||
[3H]N-methylspiperone |
![]() |
![]() |
196 | [3H]methylspiperone | |||||
[3H]N-methyl-SSR504734 |
![]() |
![]() |
4603 | [3H]-N-methyl-SSR504734 | |||||
[3H]4NMPB |
![]() |
![]() |
352 | [3H](1-methyl-4-piperidyl) 2-hydroxy-2,2-diphenyl-acetate, [3H]1-Methyl-4-piperidyl diphenylglycolate, [3H]enpiperate | |||||
[67Ga]NODAGA-[Tyr3]octreotide |
![]() |
![]() |
5628 | [67Ga]-NODAGA-Tyr3-octreotide, Ga-NODAGATOC | |||||
[3H]N/OFQ |
![]() |
![]() |
1688 | [3H]nociceptin, [3H]nociceptin/orphanin FQ, [3H]orphanin FQ | |||||
[35S]non-peptide OT antagonist |
![]() |
![]() |
3484 | [35S]-non-peptide OT antagonist | |||||
[3H]NPC17731 |
![]() |
![]() |
3831 | [3H]-NPC17731 | |||||
[125I]NPFF |
![]() |
![]() |
3797 | [125I]-neuropeptide FF, [125I]-NPFF | |||||
[125I]3-N3-Phpa-LVA |
![]() |
![]() |
2206 | ||||||
[3H](R)-NPTS |
![]() |
![]() |
4602 | [3H]-(R)-NPTS | |||||
[3H]NPVF |
![]() |
![]() |
4019 | [3H]-NPVF, [3H]neuropeptide VF | |||||
[125I]NPW-23 (human) |
![]() |
![]() |
1497 | [125I]neuropeptide W, [125I]neuropeptide W-23, [125I]NPW | |||||
[125I]NPY (human, mouse, rat) |
![]() |
![]() |
1518 | [125I]neuropeptide Y | |||||
[3H]NPY (human, mouse, rat) |
![]() |
![]() |
1521 | [3H]neuropeptide Y | |||||
O | Back to top | ||||||||
[3H]7-OH-DPAT |
![]() |
![]() |
3296 | [3H]-7-OH-DPAT | |||||
[3H]8-OH-DPAT |
![]() |
![]() |
31 | ||||||
[125I]OH-LVA |
![]() |
![]() |
2207 | ||||||
[125I]orexin A (human, mouse, rat) |
![]() |
![]() |
3798 | [125I]-orexin A | |||||
[3H]ORG2058 |
![]() |
![]() |
3454 | [3H]-ORG2058 | |||||
[11C]-ORM-13070 |
![]() |
![]() |
13182 | 11C-ORM-13070 | |||||
[3H]osanetant |
![]() |
![]() |
3480 | [3H]SR142,801, [3H]SR142801 | |||||
[3H]OSIP339391 |
![]() |
![]() |
454 | ||||||
[3H]OT (human, mouse, rat) |
![]() |
![]() |
2176 | [3H]oxytocin | |||||
[3H]5-oxo-ETE |
![]() |
![]() |
3416 | [3H]-5-oxo-ETE | |||||
[3H]oxotremorine-M |
![]() |
![]() |
8595 | ||||||
P | Back to top | ||||||||
[125I]PACAP-27 |
![]() |
![]() |
2261 | [125I]-PACAP-27, [125I]pituitary adenylate cyclase activating polypeptide-27 | |||||
[3H]PAF |
![]() |
![]() |
![]() |
1833 | [3H]platelet activating factor | ||||
[3H]paroxetine |
![]() |
![]() |
4561 | [3H]-paroxetine | |||||
[3H]PBC-264 |
![]() |
![]() |
899 | [3H]-Propionyl-BC-264, [3H]-Propionyl-BC264, [3H]propionyl-BC-264 | |||||
[125I]PD142308 |
![]() |
![]() |
3472 | ||||||
[125I]PD151242 |
![]() |
![]() |
1001 | [125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr, [125I]-PD151242 | |||||
[125I]PD164333 |
![]() |
![]() |
1002 | [125I]-PD164333 | |||||
[3H]PD128907 |
![]() |
![]() |
3298 | [3H]PD 128907, [3H]-PD128907 | |||||
[3H]PD140376 |
![]() |
![]() |
3478 | [3H]-PD140,376, [3H]PD 140376 | |||||
[3H]pemetrexed |
![]() |
![]() |
6688 | ||||||
[3H]pentazocine |
![]() |
![]() |
6683 | ||||||
[18F]PF-06684511 |
![]() |
![]() |
9832 | ||||||
[3H]PGD2 |
![]() |
![]() |
![]() |
1891 | [3H]-PGD2, [3H]11-dehydroprostaglandin F2-alpha, [3H]prostaglandin D2 | ||||
[3H]PGE2 |
![]() |
![]() |
![]() |
1916 | [3H]-PGE2, [3H]prostaglandin E2, [3H]prostin E2 | ||||
[3H]PGF2α |
![]() |
![]() |
1957 | [3H]dinoprost, [3H]prostaglandin F2alpha | |||||
[125I][Phe13,Tyr19]MCH |
![]() |
![]() |
3844 | [Phe13,[125I]Tyr19]MCH, [Phe13,[125I]Tyr19]melanin-concentrating hormone | |||||
[125I]p-iodoclonidine |
![]() |
![]() |
13179 | [125I]p-iodo-Clonidine | |||||
[3H]pirenzepine |
![]() |
![]() |
3272 | [3H]PZ | |||||
[3H]PL017 |
![]() |
![]() |
3832 | [3H]-PL017 | |||||
p-[18F]MPPF |
![]() |
![]() |
3227 | [(18)F]p-MPPF, P-[18F]MPPF | |||||
[3H]p-MPPF |
![]() |
![]() |
81 | ||||||
[125I][PP1-17,Ala31,Aib32]NPY (human) |
![]() |
![]() |
1559 | ||||||
[125I]PP (human) |
![]() |
![]() |
3800 | [125I]-pancreatic polypeptide, [125I]-PP | |||||
[3H]prazosin |
![]() |
![]() |
![]() |
5385 | [3H]-prazosin | ||||
[3H]pregnenolone sulphate |
![]() |
![]() |
![]() |
6504 | [3H]-pregnenolone sulfate | ||||
[125I]PrRP31 |
![]() |
![]() |
4022 | [125I]-PrRP31 | |||||
[125I]PrRP-20 (human) |
![]() |
![]() |
1875 | [125I]prolactin-releasing peptide-20 | |||||
[125I]psalmotoxin 1 |
![]() |
![]() |
4073 | [125I]-PcTx1 | |||||
[3H]PSB-0413 |
![]() |
![]() |
6147 | [3H]AR-C67085, [3H]AR-C67085MX | |||||
[3H]PSB-11 |
![]() |
![]() |
5729 | ||||||
[3H]PSB603 |
![]() |
![]() |
5728 | ||||||
[125I]PTA-OH |
![]() |
![]() |
1981 | I-PTA-OH | |||||
[125I](Pyr1)apelin-13 |
![]() |
![]() |
601 | ||||||
[11C]pyrilamine |
![]() |
![]() |
![]() |
3957 | [11C]-mepyramine, [11C]-pyrilamine | ||||
[3H]pyrilamine |
![]() |
![]() |
1220 | [3H]mepyramine | |||||
[3H](Pyr1)[Met(0)11]-apelin-13 |
![]() |
![]() |
604 | ||||||
[125I]PYY |
![]() |
![]() |
1519 | [125I]peptide tyrosine tyrosine, [125I]peptide YY | |||||
[125I]PYY-(3-36) (human) |
![]() |
![]() |
3802 | [125I]-peptide YY(3-36), [125I]-PYY(3-36) | |||||
[125I]PYY (pig) |
![]() |
![]() |
1520 | [125I]pPYY | |||||
Q | Back to top | ||||||||
[3H]QNB |
![]() |
![]() |
318 | [3H]quinuclidinylbenzilate | |||||
[125I]QRFP43 (human) |
![]() |
![]() |
3803 | [125I-Tyr-32]-QRFP, [125I]-pyro-glutamylated arginine-amide peptide, [125I]-QRFP | |||||
[3H]quisqualate |
![]() |
![]() |
![]() |
1370 | |||||
R | Back to top | ||||||||
[3H]R214127 |
![]() |
![]() |
1391 | [3H]-R214127 | |||||
[3H]raclopride |
![]() |
![]() |
3299 | [3H]-raclopride | |||||
[3H]ramatroban |
![]() |
![]() |
![]() |
1910 | [3H]Bay u 3405, [3H]BAY u3405, [3H]baynas | ||||
[3H]ramosetron |
![]() |
![]() |
2305 | ||||||
[3H]rauwolscine |
![]() |
![]() |
223 | ||||||
[125I]relaxin-3-B/INSL5 A chimera |
![]() |
![]() |
3789 | [125I]H3-B/INSL5 A chimera | |||||
[125I]relaxin-3 (human) |
![]() |
![]() |
1999 | [125I]H3-relaxin (human) | |||||
[125I]relaxin (human) |
![]() |
![]() |
5398 | [125I]H2 relaxin | |||||
[33P]relaxin (human) |
![]() |
![]() |
1991 | [33P]H2 relaxin (human), [33P]Human gene 2 relaxin | |||||
[3H]relcovaptan |
![]() |
![]() |
3482 | [3H] SR 49059, [3H]SR-49059, [3H]SR49059 | |||||
[125I]resiniferatoxin |
![]() |
![]() |
2492 | ||||||
[3H]resiniferatoxin |
![]() |
![]() |
![]() |
4091 | |||||
[3H]resolvin D1 |
![]() |
![]() |
![]() |
4356 | [3H]-RvD1 | ||||
[3H]resolvin E1 |
![]() |
![]() |
![]() |
2901 | [(3)H]-labeled RvE1, [3H]RvE1 | ||||
[125I]26RFa (human) |
![]() |
![]() |
10253 | ||||||
[3H]rimonabant |
![]() |
![]() |
745 | [3H]-rimonabant, [3H]-SR141716, [3H]SR141716A | |||||
R3/I5- SmBiT |
![]() |
11911 | |||||||
[3H]Ro154513 |
![]() |
![]() |
![]() |
4365 | |||||
[3H]Ro 63-0563 |
![]() |
![]() |
3246 | ||||||
[3H]robalzotan |
![]() |
![]() |
82 | [3H]NAD 299, [3H]NAD-299 | |||||
[3H]rolipram |
![]() |
![]() |
5313 | [3H]-rolipram | |||||
[3H]52770 RP |
![]() |
![]() |
1858 | ||||||
[18F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate |
![]() |
![]() |
3275 | (R,R)-[18F]-FMeQNB, (R,R)-quinuclidinyl-4-[18F]-fluoromethyl-benzilate, (R,R)-quinuclidinyl-4-[18F]-fluoromethylbenzilate(PET ligand), [18F]-FMeQNB | |||||
[3H]RS 57639 |
![]() |
![]() |
239 | RS57639 | |||||
[125I]RTI55 |
![]() |
![]() |
5409 | [125I]-RTI55, [3H]β-CIT, [3H]iometopane | |||||
[3H]RX821002 |
![]() |
![]() |
528 | [3H]2-methoxyidazoxan | |||||
[3H]RY80 |
![]() |
![]() |
4364 | ||||||
S | Back to top | ||||||||
[125I]S36057 |
![]() |
![]() |
1317 | ||||||
[125I]S70254 |
![]() |
![]() |
7779 | ||||||
[3H]S0139 |
![]() |
![]() |
3479 | [3H]-S0139, [3H]S-0139 | |||||
[3H]S-145 |
![]() |
![]() |
1984 | ||||||
[3H]S-15535 |
![]() |
![]() |
32 | ||||||
[125I]SAP |
![]() |
![]() |
1982 | [125I]-SAP, I-SAP, Isap acid | |||||
[125I]sarafotoxin S6b |
![]() |
![]() |
993 | ||||||
[125I][Sar1]Ang-II |
![]() |
![]() |
6897 | ||||||
[125I][Sar1, D-Ala8]Ang II |
![]() |
![]() |
12299 | 125I-Sarcosine1, D-Alanine8-Angiotensin II | |||||
[3H]saredutant |
![]() |
![]() |
3481 | [3H]-SR49868, [3H]SR48,968, [3H]SR48968 | |||||
[125I][Sar1,Ile8]Ang-II |
![]() |
![]() |
6906 | ||||||
[125I]sauvagine (frog) |
![]() |
![]() |
916 | ||||||
[11C]SB207145 |
![]() |
![]() |
3244 | [11C] SB207145 (PET ligand) | |||||
[123I]SB 207710 |
![]() |
![]() |
3243 | ||||||
[125I]SB-236636 |
![]() |
![]() |
2710 | ||||||
[125I]SB258585 |
![]() |
![]() |
3245 | ||||||
[3H]SB269970 |
![]() |
![]() |
3247 | ||||||
[3H]SB-674042 |
![]() |
![]() |
1706 | ||||||
[3H]SB-733993 |
![]() |
![]() |
4491 | [3H]-(2R)-3-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-2-hydroxy-S-(naphthalen-1-yl)propane-1-sulfonamido , [3H]-SB-733993 | |||||
[125I]SCH23982 |
![]() |
![]() |
945 | [125I]-SCH23982 | |||||
[3H]SCH-23390 |
![]() |
![]() |
946 | [3H]-SCH23390 | |||||
[3H]SCH 58261 |
![]() |
![]() |
431 | ||||||
[125I]SD6 |
![]() |
![]() |
7770 | ||||||
[125I]secretin (pig) |
![]() |
![]() |
1153 | ||||||
[3H]senktide |
![]() |
![]() |
3834 | [3H]-senktide | |||||
12S-[3H]HETE |
![]() |
![]() |
5508 | ||||||
[125I]SHU9119 |
![]() |
![]() |
3804 | [125I]-SHU9119 | |||||
[3H]SNAP-7941 |
![]() |
![]() |
1318 | ||||||
[32P]S1P |
![]() |
![]() |
5402 | [32P]-S1P | |||||
[18F]SPA-RQ |
![]() |
![]() |
3473 | [18F]-SPA-RQ | |||||
[125I]spexin-1 |
![]() |
![]() |
11418 | ||||||
[125I]SP (human, mouse, rat) |
![]() |
![]() |
3805 | [125I]-SP, [125I]-substance P | |||||
[3H]SP (human, mouse, rat) |
![]() |
![]() |
3835 | [3H]-SP, [3H]-substance P | |||||
[3H]spiperone |
![]() |
![]() |
![]() |
3300 | [3H]-spiperone | ||||
[125I]SQ-29548 |
![]() |
![]() |
1983 | ||||||
[3H]SQ-29548 |
![]() |
![]() |
1985 | [3H]-SQ29548, [3H]SQ-28053, [3H]SQ29548 | |||||
[3H]SR 121463A |
![]() |
![]() |
2234 | [3H]-SR121463A | |||||
[125I]Sta |
![]() |
![]() |
4850 | [125I]-Sta | |||||
[3H]strychnine |
![]() |
![]() |
![]() |
2360 | |||||
[3H]sumatriptan |
![]() |
![]() |
119 | ||||||
[3H]SYM2081 |
![]() |
![]() |
4075 | [(3)H]4MG, [3H](2S,4R)-4-methylglutamate | |||||
T | Back to top | ||||||||
[3H]T-516 |
![]() |
![]() |
11449 | ||||||
[3H]tamoxifen |
![]() |
![]() |
![]() |
5384 | [3H]-tamoxifen | ||||
TamRLX |
![]() |
11462 | |||||||
[3H]taurocholic acid |
![]() |
![]() |
![]() |
4546 | [3H]-taurocholate , [3H]-taurocholic acid | ||||
[35S]TBPS |
![]() |
![]() |
4369 | ||||||
[3H]TBZOH |
![]() |
![]() |
4766 | α-[O-methyl-3H]dihydrotetrabenazine, [3H]-TBZOH , [3H]dihydrotetrabenazine | |||||
[3H]-TCS 1102 |
![]() |
![]() |
11527 | [3H]-BBAC, [3H]-compound 18 | |||||
[14C]TEA |
![]() |
![]() |
![]() |
4575 | [14C]-TEA , tetraethylammonium | ||||
[3H](+)telenzepine |
![]() |
![]() |
8594 | ||||||
[3H]2,2,2-TEMPS |
![]() |
![]() |
6328 | [3H]-PAM | |||||
[125I]tertiapin Y1/K12/Q13 |
![]() |
![]() |
2382 | ||||||
[3H]thiamine |
![]() |
![]() |
![]() |
4628 | [3H]-thiamine, [3H]vitamin B1 | ||||
[125I]thyroxine |
![]() |
![]() |
4627 | [125I]-T4, [125I]-thyroxine | |||||
[3H]tiagabine |
![]() |
![]() |
![]() |
4685 | |||||
[3H]tiotidine |
![]() |
![]() |
3959 | [3H]-tiotidine | |||||
[3H]tiotropium |
![]() |
![]() |
8592 | ||||||
trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2 |
![]() |
![]() |
3914 | ||||||
[3H]TRH (human, mouse, rat) |
![]() |
![]() |
3836 | [3H]-thyrotropin-releasing hormone, [3H]-TRH | |||||
[125I]triptorelin |
![]() |
![]() |
1168 | [125I][D-Trp6]GnRH | |||||
[125I]TSH (human) |
![]() |
![]() |
3806 | [125I]-thyroid-stimulating hormone, [125I]-thyrotropin, [125I]-TSH | |||||
[125I]Tyr-Ala-hexarelin |
![]() |
![]() |
1095 | ||||||
[3H]tyramine |
![]() |
![]() |
![]() |
2148 | [3H]-Tyramine | ||||
[125I][Tyr4]bombesin |
![]() |
![]() |
623 | [125I-Tyr4]BN | |||||
[125I][Tyr8]bradykinin |
![]() |
![]() |
3765 | [125I]-[Tyr8]-bradykinin, [125I]-[Tyr8]BK, [125I][Tyr8]BK | |||||
[125I]Tyr0-CRF (human, rat, mouse) |
![]() |
![]() |
914 | [125I]-Tyr0-corticotropin | |||||
[125I]Tyr10-CST14 |
![]() |
![]() |
2024 | [125I]-[Tyr10]CST-14, [125I]Tyr10-cortistatin14 | |||||
[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH |
![]() |
![]() |
1165 | ||||||
[125I][Tyr11]des-Br-NPB-23 |
![]() |
![]() |
1498 | [125I][Tyr11]des-Br-neuropeptide B-23 | |||||
[125I]Tyr4-des-octanoyl-ghrelin |
![]() |
![]() |
3810 | [125I]-Tyr4-des-octanoyl-ghrelin | |||||
[125I][Tyr26]galanin (human) |
![]() |
![]() |
5391 | [125I]-[Tyr26]galanin | |||||
[125I][Tyr26]galanin (pig) |
![]() |
![]() |
6117 | ||||||
[125I][Tyr26]galanin (rat/mouse) |
![]() |
![]() |
5390 | [125I]-[Tyr26]galanin | |||||
[125I][Tyr4]ghrelin (human) |
![]() |
![]() |
1096 | [125I-Tyr4]-ghrelin, [125I-Tyr4]ghrelin | |||||
[125I]Tyr45-kisspeptin-15 |
![]() |
![]() |
1280 | [125I-Tyr45]-KP15, [125I-Tyr45]kisspeptin-15, [125I-Tyr45]KP-15 | |||||
[3H]Tyr14-N/OFQ |
![]() |
![]() |
1687 | [3H]14-Tyr-N/OFQ, [3H]14-Tyr-nociceptin, [3H]14-Tyr-nociceptin/orphanin FQ, [3H]14-Tyr-orphanin FQ | |||||
[125I]Tyr10NPS (human) |
![]() |
![]() |
1493 | human [125I]Tyr10-neuropeptide S | |||||
[125I]Tyr0-sauvagine |
![]() |
![]() |
5389 | [125I]-Tyr0-sauvagine | |||||
[125I](Tyr10)secretin-27 (rat) |
![]() |
![]() |
3759 | [125I]-(Tyr10)secretin | |||||
[125I]Tyr3 SMS 201-995 |
![]() |
![]() |
2062 | [125I][Tyr3]octreotide | |||||
[125I]Tyr11-SRIF-14 |
![]() |
![]() |
2060 | [125I]Tyr11-SS-14 | |||||
[125I]Tyr7-Sst3-ODN-8 |
![]() |
![]() |
2075 | ||||||
[125I][Tyr3,Thr8]octreotide |
![]() |
![]() |
5630 | [125I]-TOCA, [125I]-Tyr3-octreotate | |||||
U | Back to top | ||||||||
[3H]U46619 |
![]() |
![]() |
![]() |
1974 | [3H]U 46619 | ||||
[3H]U69593 |
![]() |
![]() |
1656 | [3H]-U69593 | |||||
[3H]UBP310 |
![]() |
![]() |
![]() |
4092 | |||||
[125I]U-II (human) |
![]() |
![]() |
2158 | human [125I-Tyr9] urotensin-II, human [125I] urotensin-II | |||||
[125I]urocortin 1 (mouse, rat) |
![]() |
![]() |
917 | ||||||
V | Back to top | ||||||||
[3H]valsartan |
![]() |
![]() |
![]() |
593 | |||||
[3H]vesamicol |
![]() |
![]() |
4758 | [3H]-vesamicol | |||||
[125I]VIP (human, mouse, rat) |
![]() |
![]() |
2277 | [125I]-VIP, [125I]vasoactive intestinal peptide | |||||
[11C]volinanserin |
![]() |
![]() |
3249 | [11C]M100907 (PET ligand), [11C]MDL100907 | |||||
W | Back to top | ||||||||
[11C]WAY100635 |
![]() |
![]() |
3252 | [11C]WAY-100635, [11C]WAY100635 (PET ligand) | |||||
[3H]WAY100635 |
![]() |
![]() |
3251 | ||||||
[3H]WIN35428 |
![]() |
![]() |
![]() |
4605 | [3H]-β-CFT, [3H]-2β-carboxymethy-3β-(4-fluorophenyl)tropane , [3H]-WIN35428 | ||||
[3H]WIN55212-2 |
![]() |
![]() |
736 | ||||||
X | Back to top | ||||||||
[3H]XAC |
![]() |
![]() |
![]() |
432 | [3H]xanthine amine congener | ||||
[11C]xanomeline |
![]() |
![]() |
3278 | [11C]xanomeline (PET ligand) | |||||
[125I]XCL1 (human) |
![]() |
![]() |
857 | [125I]ATAC, [125I]lymphotactin, [125I]SCM-1α | |||||
Y | Back to top | ||||||||
[3H]YM298198 |
![]() |
![]() |
5392 | [3H]-YM298198 | |||||
[125I]Y-RFRP-3 |
![]() |
![]() |
1484 | [125I]YVP | |||||
yttrium (90Y) clivatuzumab tetraxetan |
![]() |
![]() |
8087 | 90Y-hPAM4, hPAM4, hPAM4-Cide, IMMU-107 | |||||
Z | Back to top | ||||||||
[3H](S)-zacopride |
![]() |
![]() |
4074 | ||||||
[125I]ZM-241385 |
![]() |
![]() |
430 | ||||||
[3H]ZM 241385 |
![]() |
![]() |
455 | [3H]-ZM241385 | |||||
[3H]zolpidem |
![]() |
![]() |
![]() |
4362 | |||||